Archive for August 2023
Advanced AI prompts new questions over intellectual property
We asked intellectual property attorneys in Boston for their thoughts on who should get credit for work created through generative AI. Read More
Read MoreThe Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab
A Watertown biotech trimmed its pipeline again, setting aside all of its experimental drugs except one. It’s the second time the company has cut programs this year. Plus other life sciences news you may have missed. Read More
Read MoreDollar Tree to pay $1.34M to settle workplace safety violation claims
OSHA said Wednesday it entered into a corporate-wide settlement agreement with Dollar Tree Inc. one of the nation’s largest discount retail chains, to address problems including blocked exits, access to fire extinguishers, and improper material storage. Read More
Read MoreLargest IP Law Firms in Massachusetts
List is ranked by number of intellectual property lawyers in Massachusetts as of Aug. 1, 2023. Number of Mass. IP lawyers includes only those who spend at least 75% of their time devoted to IP law matters. Number of patents/filed obtained refers to those filed/obtained by firm’s Mass. office(s) in 2022 on behalf of both…
Read MoreGroup that sued Harvard over affirmative action targets law firm with Boston office
After winning his case against Harvard over affirmative action, Edward Blum is looking to strike down fellowships aimed at bolstering diversity at law firms, including at one law firm with a Boston presence. Read More
Read MoreFenway Sports Group signs marketing deal with women’s golf league
A marketing arm of the Fenway Sports Group has signed a marketing deal with the women’s golf league LPGA. Read More
Read MoreBlue Cross Blue Shield appoints new chief consumer experience officer
Paul Long is the new chief consumer experience officer at the states largest health plan. Read More
Read MoreWatertown biotech shares spike after accidental data publication at Roche
The Swiss drug giant inadvertently published promising data from a lung cancer drug trial, boosting shares of biotechs developing similar drugs, including iTeos Therapeutics. Read More
Read MoreLexington biotech lays off 91 as it narrows focus
A Lexington biotech is laying off 91 workers as it trims its pipeline down to just two drugs. Read More
Read MoreToast is just warming up, despite recent missteps
The restaurant-technology provider has seen its stock slide since its IPO during the pandemic. But now, it’s hitting some of its financial milestones ahead of schedule and planning to add enterprise customers to its growing customer base. Read More
Read More